Filing Details

Accession Number:
0001140361-16-076060
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-12 10:44:40
Reporting Period:
2016-08-10
Filing Date:
2016-08-12
Accepted Time:
2016-08-12 10:44:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561387 Health Insurance Innovations Inc. HIIQ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1317254 Patrick Mcnamee C/O Health Insurance Innovations, Inc.
15438 North Florida Ave., Suite 201
Tampa FL 33613
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2016-08-10 15,000 $4.52 40,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class A Common Stock Stock Appreciation Rights $4.33 2020-11-09 425,000 425,000 Direct
Class A Common Stock Stock Appreciation Rights $6.77 2021-05-25 125,000 125,000 Direct
Class A Common Stock Stock Appreciation Rights $4.72 2022-06-08 300,000 300,000 Direct
Class A Common Stock Stock Appreciation Rights $7.02 2023-06-08 172,090 172,090 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-11-09 425,000 425,000 Direct
2021-05-25 125,000 125,000 Direct
2022-06-08 300,000 300,000 Direct
2023-06-08 172,090 172,090 Direct
Footnotes
  1. Shares previously held indirectly as trustee of the McNamee Trust U/A Dated 2/13/09 were transferred to the reporting person and are now held directly, in a transaction exempt from Section 16 reporting pursuant to Rule 16a-13.
  2. These stock-settled stock appreciation rights were previously granted under the Issuer's Long-Term Incentive Plan ("Plan") and vest as follows: (i) 125,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $8.00 per share for the preceding 30 consecutive trading days, (ii) 250,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $12.00 per share for the preceding 30 consecutive trading days and (iii) 50,000 on the first date on which the average trading price of the Company's Class A common stock is at or above $16.00 per share for the preceding 30 consecutive trading days, all subject to the terms of the Plan and an award agreement under the Plan.
  3. These stock-settled stock appreciation rights were granted under the Plan and will vest on the first date on which the average trading price of the Company's Class A common stock is at or above $16.00 per share for the preceding 30 consecutive trading days, subject to the terms of the Plan and an award agreement under the Plan.
  4. These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments as follows: 25% on June 8, 2016; 25% on June 8, 2017; and 50% on June 8, 2018, subject to the terms of the Plan and an award agreement under the Plan.
  5. These stock-settled stock appreciation rights were granted under the Plan pursuant to the reporting person's employment agreement and are scheduled to vest in increments as follows: 25% on June 8, 2017, 25% on June 8, 2018, and 50% on June 19, 2019.